Ex vivo erythrocyte generation and blood doping

Blood Transfusion

Volumn 11, Issue 2, 2013, Pages 161-163

  Lombardi, Giovanni ^a   Banfi, Giuseppe ^a,b   Lippi, Giuseppe ^c   Sanchis Gomar, Fabian ^d  

^a IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY HOSPITAL OF PARMA   (Italy)

^d UNIVERSITY OF VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ATHLETE; BLOOD AUTOTRANSFUSION; BLOOD DONOR; BLOOD TRANSFUSION; DOPING; EDITORIAL; ERYTHROCYTE; EX VIVO STUDY; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; PLURIPOTENT STEM CELL; RECIPIENT; SPORTING EVENT;

BLOOD TRANSFUSION, AUTOLOGOUS; DOPING IN SPORTS; ERYTHROCYTE TRANSFUSION; ERYTHROCYTES; HEMATOPOIETIC STEM CELLS; HUMANS; INDUCED PLURIPOTENT STEM CELLS;

EID: 84876923887     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2012.0028-12     Document Type: Editorial

References (25)

1. Lippi G, Franchini M, Salvagno GL, Guidi GC. Biochemistry, physiology, and complications of blood doping: facts and speculation. Crit Rev Clin Lab Sci 2006;43:349-91. (Pubitemid 43884643)
2. Lippi G, Franchini M, Banfi G. Biochemistry and physiology of anabolic androgenic steroids doping. Mini Rev Med Chem 2011;11:362-73.
3. WADA: World Anti-Doping Agency. The 2012 prohibited list - international standard. Available at: http://www.wadaama.org/Documents/World-Anti-Doping- Program/WADPProhibitedlist/2012/WADA-Prohibited-List-2012-EN.pdf. Accessed on: 22/12/2011.
4. WADA: World Anti-Doping Agency. World Anti-Doping Code. Available at: http://www.wada-ama.org/Documents/World-Anti-Doping-Program/WADP-The-Code/ WADA-Anti-Doping-CODE-2009-EN.pdf. Accessed on: 22/12/2011.
5. Jelkmann W, Lundby C. Blood doping and its detection. Blood 2011;118:2395-404.
6. Morkeberg J. Detection of autologous blood transfusions in athletes: a historical perspective. Transfus Med Rev 2012;26(3):199-208.
7. Lippi G, Banfi G. Blood transfusions in athletes. Old dogmas, new tricks. Clin Chem Lab Med 2006;44:1395-402. (Pubitemid 44967686)
8. Giraud S, Sottas PE, Robinson N, Saugy M. Blood transfusion in sports. Handb Exp Pharmacol 2010;195:295-304.
9. Monfort N, Ventura R, Platen P, et al. Plasticizers excreted in urine: indication of autologous blood transfusion in sports. Transfusion 2011;52:647-57.
10. Banfi G, Franchini M, Lippi G. Letter to the editor regarding "Rapid determination of urinary di (2-ethylhexyl) phthalate metabolites based on liquid chromatography/tandem mass spectrometry as a marker for blood transfusion in sports drug testing". Anal Bioanal Chem 2011;401:577-8.
11. Solymos E, Guddat S, Geyer H, et al. Di (2-ethylhexyl) phthalate metabolites as markers for blood transfusion in doping control: Intra-individual variability of urinary concentrations. Drug Test Anal 2011;3:892-5.
12. Zorzoli M, Rossi F. Implementation of the biological passport: The experience of the International Cycling Union. Drug Test Anal 2010;2:542-7.
13. Sallet P, Brunet-Guedj E, Mornex R, Baverel G. Study of a new indirect method based on absolute norms of variation to detect autologous blood transfusion. Int J Hematol 2008;88:362-8.
14. Morkeberg J, Sharpe K, Belhage B, et al. Detecting autologous blood transfusions: a comparison of three passport approaches and four blood markers. Scand J Med Sci Sports 2011;21:235-43.
15. Pottgiesser T, Sottas PE, Echteler T, et al. Detection of autologous blood doping with adaptively evaluated biomarkers of doping: a longitudinal blinded study. Transfusion 2011;51:1707-15.
16. Yachie-Kinoshita A, Nishino T, Shimo H, et al. A metabolic model of human erythrocytes: practical application of the E-cell simulation environment. J Biomed Biotechnol 2010;2010:642420.
17. Haghgooie R, Toner M, Doyle PS. Squishy non-spherical hydrogel microparticles. Macromol Rapid Commun 2010;31:128-34.
18. Doshi N, Zahr AS, Bhaskar S, et al. Red blood cell-mimicking synthetic biomaterial particles. Proc Natl Acad Sci USA 2009;106:21495-9.
19. Lippi G, Franchini M, Banfi G. Red blood cell-mimicking synthetic biomaterial particles: the new frontier of blood doping? Int J Sports Med 2010;31:75-6.
20. Timmins NE, Nielsen LK. Blood cell manufacture: current methods and future challenges. Trends Biotechnol 2009;27:415-22.
21. Giarratana MC, Kobari L, Lapillonne H, et al. Ex vivo generation of fully mature human red blood cells from hematopoietic stem cells. Nat Biotechnol 2005;23:69-74. (Pubitemid 41724627)
22. Lapillonne H, Kobari L, Mazurier C, et al. Red blood cell generation from human induced pluripotent stem cells: perspectives for transfusion medicine. Haematologica 2010;95:1651-9.
23. Giarratana MC, Rouard H, Dumont A, et al. Proof of principle for transfusion of in vitro-generated red blood cells. Blood 2011;118:5071-9.
24. Lippi G, Montagnana M, Franchini M. Ex-vivo red blood cells generation: a step ahead in transfusion medicine? Eur J Intern Med 2011;22:16-9.
25. Timmins NE, Athanasas S, Gunther M, et al. Ultra-high-yield manufacture of red blood cells from hematopoietic stem cells. Tissue Eng Part C Methods 2011;17:1131-7.